Breastcancer.org Podcast

Emily Garnett talks about what it's like to walk in the AnaOno fashion show and what it means for people with metastatic disease.

Barbara Bigelow talks about her experience with metastatic breast cancer and what walking in the AnaOno fashion show means for her.

Bret Miller found a lump in his right breast when he was 17 and was finally diagnosed with breast cancer at age 24. His journey led him to found the Bret Miller 1T Foundation and the Male Breast Cancer Coalition. Running time: 12:03

Kelly Owens, director of education and research for FORCE, explains the organization's XRAYS (eXamining the Relevance of Articles for Young Survivors) program. Running time: 3:44

Dr. Zaida Morante, medical oncologist at Instituto Nacional de Enfermedades Neoplásicas in Lima, Peru, explains her research that found delaying chemotherapy for more than 30 days was associated with worse outcomes in women diagnosed with early-stage, triple-negative breast cancer. Triple-negative breast cancer is breast cancer that is estrogen-receptor-negative, progesterone-receptor-negative, and HER2-negative. Listen to the podcast to hear Dr. Morante explain: the design of the study which outcomes delaying chemotherapy affected possible explanations for why chemotherapy was delayed for some women Running time: 7:07

Roberto Leon-Ferre, M.D., breast oncologist at the Mayo Clinic, discusses the research he presented at the 2018 San Antonio Breast Cancer Symposium evaluating the effectiveness of oxybutynin, a medicine commonly used to treated bladder incontinence, to treat hot flashes in women who can't take hormone replacement therapy, which includes most women treated for breast cancer. Listen to the podcast to hear Dr. Leon-Ferre explain: the design of the study why he thought oxybutynin might be able to ease hot flashes possible side effects of long-term use of oxybutynin and why the medicine may still be useful for women who have been treated for breast cancer Running time: 9:53

Dr. Laura Dominici, surgeon at the Dana-Farber/Brigham and Women's Cancer Center, assistant professor of surgery at Harvard Medical School, and division chief of breast surgery at Brigham and Women's Faulkner Hospital, discusses the research she presented at the 2018 San Antonio Breast Cancer Symposium looking at how the type of breast cancer surgery affected quality of life in women 40 and younger who had been diagnosed with breast cancer. Listen to the podcast to hear Dr. Dominici explain: the design of the study what we can and can't infer from the results why she hopes these results will lead to better communication between doctors and patients Running time: 10:13

Shirley Mertz, president of the Metastatic Breast Cancer Network and chair of the Metastatic Breast Cancer Alliance, has been living with metastatic disease for 15 years. She talks about the increasing body of research on metastatic breast cancer at the San Antonio Breast Cancer Symposium. Running time: 2:47

Christine Benjamin, breast cancer program director for SHARE Cancer Support and vice chair of the Metastatic Breast Cancer Alliance, explains some of the new programs each organization will roll out in 2019. Running time: 2:55

Matthew Goetz, M.D., professor of oncology at the Mayo Clinic where he is also co-leader of the Women's Cancer Program and chair of the Breast Cancer Disease-Oriented Group, discusses the research he presented at the 2018 San Antonio Breast Cancer Symposium on patient-reported outcomes from women being treated with Verzenio (chemical name: abemaciclib) plus an aromatase inhibitor as the first treatment for advanced-stage, hormone-receptor-positive, HER2-negative breast cancer. Listen to the podcast to hear Dr. Goetz talk about: what patient-reported outcomes are and why they're important for both doctors and patients the Verzenio side effects reported in the study how diarrhea caused by Verzenio can be proactively managed so a woman doesn't have to plan her life around a side effect Running time: 9:31

Kelly Hogan received her undergraduate degree in journalism from Northeastern University and her nutrition education, training, and master’s degree in clinical nutrition from New York University. As the nutrition and wellness manager at the Dubin Breast Center at Mount Sinai Hospital in New York City, Kelly incorporates a holistic approach, focusing not only on nutrition, but overall wellness including physical activity, stress management, and sleep. Before the Dubin Breast Center, Kelly worked with the general surgery and oncology inpatient populations at Mount Sinai.Listen to the podcast to hear Kelly discuss: how people who want to eat healthy can have fun and not feel left out or hungry why the holidays are a great time for creative mocktails how some traditional holiday dishes can be modified to be a bit healthier what she’s making for her Thanksgiving dinner Running time: 14:34

Kyle Woody is cofounder and executive director of Jack’s Caregiver Coalition, a community of men who are cancer caregivers. Kyle believes that one of the biggest and most important challenges a man can face in his lifetime is engaging as a caregiver for a loved one with a serious disease such as cancer. Kyle believes that every man has the potential to rise to that challenge and be his boldest and most confident self. Reflecting on his experience as a primary caregiver for his spouse with metastatic colon cancer, he realized the principles of excellence and sound teamwork that he preached in his professional career should have been applied at home in his caregiving experience, which is why he helped found Jack’s in 2014 to improve the way men think, feel, and act in their role as cancer caregivers.Listen to the podcast to hear Kyle talk about: how Jack’s was founded some of the programs Jack’s offers to help men who are caregivers some things that he’d like men who are cancer caregivers to know why caregiving

Catherine Guthrie is a women’s health journalist with two decades of experience in the magazine and publishing industry. She has written for Cosmopolitan; O, The Oprah Magazine; Slate; Time; and Better Homes and Gardens, among others. In 2009, at age 38, Catherine was diagnosed with breast cancer. Although the cancer was only in one breast, she opted for a double mastectomy and chose not to reconstruct. She was diagnosed with breast cancer a second time a year later in 2010. During her treatment, she searched for a memoir where the narrator grappled with the reality of the disease, where she unpacked questions about reconstruction, and challenged the tacit assumptions about what women want or need to feel whole after cancer. She couldn’t find a book that filled that niche, so she wrote one. Catherine’s queer, feminist memoir, FLAT: Reclaiming My Body From Breast Cancer, was published in September 2018. Listen to the podcast to hear Catherine discuss: “the male gaze” and how it informs breast reconstructio

Michael Stubblefield, M.D. is medical director of cancer rehabilitation at the Kessler Institute for Rehabilitation in New Jersey and the national medical director for Select Medical’s ReVital Cancer Rehabilitation program. He is known around the world for his expertise in the identification, evaluation, and rehabilitation of pain and functional disorders caused by cancer and cancer treatments, particularly problems caused by radiation and chemotherapy. Dr. Stubblefield is an accomplished researcher and has published extensively on medical rehabilitation, oncology, pain management, palliative care, and neurophysiology. Listen to the podcast to hear Dr. Stubblefield explain: the definition of post-mastectomy pain syndrome and the different ways it affects people how surgeries and radiation can cause this pain syndrome treatments for post-mastectomy pain syndrome the three things that anyone experiencing post-mastectomy pain syndrome should know Running time: 29:38

An adult nurse practitioner, Dori Klemanski, DNP, CNP is clinical director of survivorship at the Ohio State University Comprehensive Cancer Center-James Cancer Hospital and Solove Research Institute. In this role she helps identify the unmet needs of cancer survivors, as well as late- and long-term effects of treatment. She also oversees the creation of survivorship care plans to meet the long-term needs of survivors.Listen to the podcast to hear Klemanski explain: what a survivorship care plan is and the information included in one why it’s so important that a survivorship care plan be personalized who creates a survivorship care plan how to get a survivorship care plan if you don’t have one Running time: 26:10

Michael Stubblefield, M.D. is medical director of cancer rehabilitation at the Kessler Institute for Rehabilitation in New Jersey and the national medical director for Select Medical’s ReVital Cancer Rehabilitation program. He is known around the world for his expertise in the identification, evaluation, and rehabilitation of pain and functional disorders caused by cancer and cancer treatments, particularly problems caused by radiation and chemotherapy. Dr. Stubblefield is an accomplished researcher and has published extensively on medical rehabilitation, oncology, pain management, palliative care, and neurophysiology.Listen to the podcast to hear Dr. Stubblefield explain: what neuropathy is, how it happens, and the treatments that can cause it how to explain neuropathy to friends and family risk factors for neuropathy treatments for neuropathy the three things that anyone diagnosed with neuropathy should know Running time: 31:32

Dr. Frank DellaCroce, or "Dr. D" as he has come to be known, is a founding partner of the Center for Restorative Breast Surgery and St. Charles Surgical Hospital in New Orleans. Board-certified in plastic surgery, Dr. D has performed thousands of reconstructive procedures, both for women diagnosed with breast cancer and women at high risk of the disease who choose to have prophylactic breast removal. He is a Fellow of the American College of Surgeons and a member of numerous professional societies, including the American Society of Plastic and Reconstructive Surgery, the American Society for Reconstructive Microsurgery, and the World Society for Reconstructive Microsurgery. He also has been named one of the "Best Doctors in America."Listen to the podcast to hear Dr. D discuss: why a woman might consider revision reconstruction the results of revision reconstruction: what to expect, as well as recovery and side effects questions to ask a plastic surgeon if you’re considering revision reconstruction Running t

Dr. Utthara Nayar is a research fellow in medicine at the Dana-Farber Cancer Institute, the Harvard Medical School, and the Broad Institute of MIT and Harvard. A cancer biologist, her broad research focuses on the interface of basic biology, targeted medicines, and drug resistance. At the 2018 American Association for Cancer Research Annual Meeting, she presented research looking at how acquired HER2 mutations can make some metastatic hormone-receptor-positive breast cancers resistant to hormonal therapy. Listen to the podcast to hear Dr. Nayar explain: the number of metastatic hormone-receptor-positive breast cancers that become resistant to hormonal therapy what whole exome sequencing is and why she and her colleagues used it in this study the possibility that genetic sequencing of cancers could be an ongoing part of treatment at some point in the future Running time: 15:08

Dr. C. Kent Osborne is director of the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine, where he is also a professor and the Dudley and Tina Sharp Chair for Cancer Research. Since 1992, he has been a codirector of the San Antonio Breast Cancer Symposium, the world's largest conference focusing entirely on breast cancer. His own research focuses on improving the effectiveness of hormonal therapy medicines and targeted therapies that treat HER2-positive disease. At the 2018 American Association for Cancer Annual Meeting, Dr. Osborne was honored with the 2018 AACR Distinguished Award for Extraordinary Scientific Achievement and Leadership in Breast Cancer Research, in part for his stewardship of the San Antonio Symposium. Listen to the podcast to hear Dr. Osborne discuss: how our understanding of breast cancer has changed since the 1970s the most promising areas of breast cancer research going on right now the feasibility of a cure for breast cancer Running time: 12:06

Desirée Walker, who calls herself a two-time breast cancer "victor," talks about her poster on the importance of involving patients in breast cancer research projects.Running time: 5:23